These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 28828971)
41. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area. Jeon MJ; Chun SM; Kim D; Kwon H; Jang EK; Kim TY; Kim WB; Shong YK; Jang SJ; Song DE; Kim WG Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298 [TBL] [Abstract][Full Text] [Related]
42. Case report: different metastatic components from anaplastic thyroid carcinoma in mediastinal and neck lymph nodes simultaneously diagnosed by FNA. Costaldi ME; Zhou Z Diagn Cytopathol; 2014 Aug; 42(8):694-9. PubMed ID: 23729380 [TBL] [Abstract][Full Text] [Related]
43. Anaplastic Carcinoma Thyroid in a Young Child - an Extremely Rare Occurrence. Sharma SC; Sakthivel P; Raveendran S; Singh CA; Nakra T; Agarwal S Acta Medica (Hradec Kralove); 2018; 61(4):150-152. PubMed ID: 30664448 [TBL] [Abstract][Full Text] [Related]
45. Molecular genetic markers for thyroid FNAB. Established assays and future perspective. Musholt TJ; Musholt PB Nuklearmedizin; 2015; 54(3):94-100. PubMed ID: 26105717 [TBL] [Abstract][Full Text] [Related]
46. PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. Bellevicine C; Iaccarino A; Malapelle U; Sasso FC; Biondi B; Troncone G Eur J Endocrinol; 2013 Sep; 169(3):307-11. PubMed ID: 23811186 [TBL] [Abstract][Full Text] [Related]
47. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Wiseman SM; Griffith OL; Deen S; Rajput A; Masoudi H; Gilks B; Goldstein L; Gown A; Jones SJ Arch Surg; 2007 Aug; 142(8):717-27; discussion 727-9. PubMed ID: 17709725 [TBL] [Abstract][Full Text] [Related]
49. Recent developments in the clinical application of thyroid cancer biomarkers. Shibru D; Chung KW; Kebebew E Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251 [TBL] [Abstract][Full Text] [Related]
50. The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules. Sidoti M; Marino G; Resmini E; Augeri C; Cappi C; Cavallero D; Lagasio C; Ceppa P; Minuto F; Giusti M Minerva Endocrinol; 2006 Jun; 31(2):159-72. PubMed ID: 16682939 [TBL] [Abstract][Full Text] [Related]
51. The utility of molecular markers in pre-operative assessment of thyroid nodules. Bhatia P; Abd Elmageed ZY; Friedlander P; Aslam R; Kandil E Future Oncol; 2015; 11(16):2343-50. PubMed ID: 26260812 [TBL] [Abstract][Full Text] [Related]
52. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators. Geraldo MV; Kimura ET PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459 [TBL] [Abstract][Full Text] [Related]
53. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations]. Hayashi N; Kitaoka M Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562 [TBL] [Abstract][Full Text] [Related]
54. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD. Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310 [TBL] [Abstract][Full Text] [Related]
55. Molecular Testing of Thyroid Nodules: A Review of Current Available Tests for Fine-Needle Aspiration Specimens. Zhang M; Lin O Arch Pathol Lab Med; 2016 Dec; 140(12):1338-1344. PubMed ID: 27557410 [TBL] [Abstract][Full Text] [Related]
56. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material. Kartal K; Onder S; Kosemehmetoglu K; Kilickap S; Tezel YG; Kaynaroglu V BMC Cancer; 2015 Oct; 15():824. PubMed ID: 26519197 [TBL] [Abstract][Full Text] [Related]
57. Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling Pathways. Samimi H; Fallah P; Naderi Sohi A; Tavakoli R; Naderi M; Soleimani M; Larijani B; Haghpanah V Acta Med Iran; 2017 Mar; 55(3):200-208. PubMed ID: 28282720 [TBL] [Abstract][Full Text] [Related]
58. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Zhao L; Dias-Santagata D; Sadow PM; Faquin WC Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645 [TBL] [Abstract][Full Text] [Related]
59. Osteoclastic variant of anaplastic thyroid carcinoma: A case report of rare entity. Shelly D; Gupta D; Mishra S; Bharadwaj R J Cancer Res Ther; 2019; 15(3):704-707. PubMed ID: 31169246 [TBL] [Abstract][Full Text] [Related]
60. Nanotechnological Advancements for the Theranostic Intervention in Anaplastic Thyroid Cancer: Current Perspectives and Future Direction. Uppalapati SS; Guha L; Kumar H; Mandoli A Curr Cancer Drug Targets; 2024; 24(3):245-270. PubMed ID: 37424349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]